Short-Term Heart Disease Risks of Combination Menopausal Hormone Therapy Confirmed
ScienceDaily (Feb. 19, 2010) — New analyses from the Women’s Health Initiative (WHI) confirm that combination hormone therapy increases the risk of heart disease in healthy postmenopausal women. Researchers report a trend toward an increased risk of heart disease during the first two years of hormone therapy among women who began therapy within 10 years of menopause, and a more marked elevation of risk among women who began hormone therapy more than 10 years after menopause. Analyses indicate that overall a woman’s risk of heart disease more than doubles within the first two years of taking combination HT.
NIH/National Heart, Lung and Blood Institute. “Short-Term Heart Disease Risks of Combination Menopausal Hormone Therapy Confirmed.” ScienceDaily 19 February 2010.
Click below for full article